ContractCommon Stock Purchase Warrant • August 15th, 2018 • Glucose Biosensor Systems (Greater China) Holdings, Inc. • Surgical & medical instruments & apparatus • New York
THE REGISTERED HOLDER OF THIS PURCHASE WARRANT BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS PURCHASE WARRANT EXCEPT AS HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS PURCHASE WARRANT AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR HYPOTHECATE THIS PURCHASE WARRANT FOR A PERIOD OF ONE HUNDRED EIGHTY DAYS FOLLOWING [●], 2018 (THE “EFFECTIVE DATE”) TO ANYONE OTHER THAN (I) CUTTONE & CO., LLC OR A SELECTED DEALER IN CONNECTION WITH THE OFFERING FOR WHICH THIS PURCHASE WARRANT WAS ISSUED TO THE PLACEMENT AGENT AS CONSIDERATION (THE “OFFERING”), OR (II) A BONA FIDE OFFICER OR PARTNER OF CUTTONE & CO., LLC.
SCHEDULE 1 – PARTIES TO MSA 4 SCHEDULE 2 – GENERAL TERMS AND CONDITIONS 5Master Services Agreement • August 15th, 2018 • Glucose Biosensor Systems (Greater China) Holdings, Inc. • Surgical & medical instruments & apparatus
to all other parties at either the postal address, facsimile number or email address specified for the parties at Schedule 1.
Medical Affairs Service AgreementGlucose Biosensor Systems (Greater China) Holdings, Inc. • August 15th, 2018 • Surgical & medical instruments & apparatus • New South Wales
Recitals 1 The Client requires the Services to be provided by CRC. 2 CRC agrees to provide the Services to the Client on the terms and conditions of this Agreement.
SUBSCRIPTION AGREEMENTSubscription Agreement • August 15th, 2018 • Glucose Biosensor Systems (Greater China) Holdings, Inc. • Surgical & medical instruments & apparatus • New York
THIS INVESTMENT INVOLVES A HIGH DEGREE OF RISK. THIS INVESTMENT IS SUITABLE ONLY FOR PERSONS WHO CAN BEAR THE ECONOMIC RISK FOR AN INDEFINITE PERIOD OF TIME AND WHO CAN AFFORD TO LOSE THEIR ENTIRE INVESTMENT. FURTHERMORE, INVESTORS MUST UNDERSTAND THAT THE MARKET FOR SUCH INVESTMENT MAY BE LIMITED AND SPORADIC AND IS EXPECTED TO CONTINUE TO BE LIMITED AND SPORADIC FOR AN INDEFINITE PERIOD OF TIME. NO PUBLIC MARKET CURRENTLY EXISTS FOR THE SECURITIES.
Lock-Up AgreementLock-Up Agreement • August 15th, 2018 • Glucose Biosensor Systems (Greater China) Holdings, Inc. • Surgical & medical instruments & apparatus
THIRD VARIATION AGREEMENT TO TECHNOLOGY LICENCE AGREEMENTThird Variation Agreement • August 15th, 2018 • Glucose Biosensor Systems (Greater China) Holdings, Inc. • Surgical & medical instruments & apparatus
This Third Variation Agreement to the Technology License Agreement (this “Third Variation Agreement”) dated as 10 July 2018 (the “Effective Date”), is by and between Life Science Biosensor Diagnostics Pty Ltd., an Australian proprietary limited company having an address at Level 9,85 Castlereagh Street, Sydney NSW 2000 Australia “Licensor” and Glucose Biosensor Systems (Greater China) Holdings Inc. , a company having an registered office at Corporation Trust Centre, 1209 Orange St, City of Wilmington, County of New Castle, Delaware 19801 (“Licensee”) (each, a “Party” and collectively the “Parties”).
Services AgreementServices Agreement • August 15th, 2018 • Glucose Biosensor Systems (Greater China) Holdings, Inc. • Surgical & medical instruments & apparatus • New York
This Services Agreement (this “Agreement”), dated as of 13 Aug 2018 , is made by and between Glucose Biosensor Systems (Greater China) Holdings Inc., a Delaware limited liability company (together with any successor thereto, the “Company”), and Becker Clinical Research Consulting, LLC (the “Service Provider”) (collectively referred to herein as the “Parties”).
